Brain Cancer

However, small trial failed to meet overall response endpoint in patients with recurrent disease

Device allows delivery of more potent chemotherapies to patients with glioblastomas

In U.K. cohort study, no cases of transmission observed

Response rate with dabrafenib plus trametinib was four times higher versus standard chemotherapy

Across both subtypes, improved survival seen with at least 75% resection, study finds

Study suggests one radiation-induced brain cancer expected per 10,000 persons receiving a head CT

If I wasn't believed when seeking care, what chance do non-physicians have?

Experts weigh in on why the topic has seemed to lose steam in recent years

Phase I trial shows encouraging OS in children with diffuse intrinsic pontine glioma

Despite poorer induction responses, survival no different compared to kids going straight to ASCT

ORR quadrupled, median PFS nearly tripled with dabrafenib plus trametinib in low-grade disease

Worse 5-year OS in Hispanic children with high-risk neuroblastoma in adjusted analysis

Suspicions are raised at a New Jersey high school, but the road ahead is likely a long one

A look at the infant's condition